Cogent Biosciences (COGT) Free Cash Flow (2017 - 2021)
Historic Free Cash Flow for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to -$21.2 million.
- Cogent Biosciences' Free Cash Flow fell 12645.74% to -$21.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$60.4 million, marking a year-over-year decrease of 6836.54%. This contributed to the annual value of -$208.4 million for FY2024, which is 3320.8% down from last year.
- Latest data reveals that Cogent Biosciences reported Free Cash Flow of -$21.2 million as of Q4 2021, which was down 12645.74% from -$15.3 million recorded in Q3 2021.
- Cogent Biosciences' Free Cash Flow's 5-year high stood at -$6.0 million during Q2 2017, with a 5-year trough of -$21.2 million in Q4 2021.
- Its 5-year average for Free Cash Flow is -$9.9 million, with a median of -$8.7 million in 2018.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 3172.15% in 2020, then tumbled by 12645.74% in 2021.
- Cogent Biosciences' Free Cash Flow (Quarter) stood at -$6.6 million in 2017, then crashed by 36.34% to -$9.0 million in 2018, then increased by 6.23% to -$8.5 million in 2019, then dropped by 10.74% to -$9.4 million in 2020, then tumbled by 126.46% to -$21.2 million in 2021.
- Its last three reported values are -$21.2 million in Q4 2021, -$15.3 million for Q3 2021, and -$12.5 million during Q2 2021.